Skip to main content
. 2018 Jul 17;20:286–296. doi: 10.1016/j.nicl.2018.07.016

Fig. 1.

Fig. 1

Mean baseline performance (top chart) and change over 24 months (bottom chart) for the ADAS-cog 13 subitems for dementia-AD (AD), MCI-AD (MCI) and cognitively unimpaired (CU) subjects. Results are illustrated as percentage of the maximum possible value, with higher values indicating worse performance. Significant group differences are indicated by * (ANOVA: *p < .5; **p < .001; ***p < .0001; for detailed p-values see Table 1 and Table S1) with the corresponding between group differences below in brackets (i.e. Duncan's multiple range test).